How Much Dietary Fiber Do We Need to be Healthy? (SNP48)

Introduction to this Episode

This episode examines dietary fiber through the lens of a practical, clinically relevant question: if higher fiber intakes are consistently associated with reduced chronic disease risk, what intake level should we be aiming for to meaningfully improve health outcomes?

The discussion deliberately spans from common online claims that fiber is “not essential” (and therefore unnecessary), through to mechanistic reasoning and the highest-quality evidence we have for hard outcomes and accepted intermediate cardiometabolic endpoints.

Across the episode, weʼll hear from six expert perspectives to integrate epidemiology, controlled feeding studies, and clinical guideline contexts.

We will consider how the dose–response patterns, fiber type/source, individual tolerance, and the limitations of nutrition trials all influence what can be recommended with confidence.

Experts that appear in this episode:

• Joanne Slavin – Professor of nutrition science whose research focuses on dietary fiber, whole grains, and their role in metabolic and cardiometabolic health.
• Andrew Reynolds – Nutrition epidemiologist specialising in carbohydrate quality, dietary fiber, and diet–disease relationships in large population studies.
• David Jenkins – Professor of nutrition and metabolism best known for developing the Portfolio Diet and for seminal work on cholesterol-lowering dietary strategies.
• Kathryn Bradbury – Epidemiologist whose research examines diet, lifestyle factors, and risk of colorectal and other cancers.
• Andrea Glenn – Nutrition epidemiologist researching cardiometabolic disease risk, with a focus on plant-based and portfolio-style dietary patterns.
• Alan Flanagan – Postdoctoral researcher specialising in chrononutrition, circadian biology, and their implications for cardiometabolic health.

Useful Terminology for this Episode

• Dietary fiber: Non-digestible carbohydrate (and related compounds) intrinsic to plant foods that resists digestion in the small intestine and may be fermented in the colon; it influences stool bulk, transit, microbial metabolism, and multiple cardiometabolic risk factors.
• Functional fiber: Isolated or synthetic non-digestible carbohydrates added to foods that may be counted as “fiber” on labels only if they demonstrate an accepted physiological benefit; this concept is central to how regulators define and label fiber.
• Viscous fiber: A subset of soluble fibers (e.g., beta-glucans, pectin, psyllium) that form gels in the gut, increasing intestinal viscosity and contributing to LDL-cholesterol lowering via effects on bile acid reabsorption.
• Resistant starch: Starch that resists digestion in the small intestine and reaches the colon for fermentation; it behaves “fiber-like” physiologically, but is not always counted within conventional fiber definitions used in dietary assessment.
• Short-chain fatty acids (SCFAs): Fermentation products (e.g., acetate, propionate, butyrate) generated by gut microbes from fermentable fibers and resistant starch; they are often discussed in relation to gut barrier function and intestinal inflammation.
• Secondary bile acids: Bile acids modified by gut microbes; higher levels are discussed as potentially undesirable in colorectal carcinogenesis pathways, particularly in contexts of low fiber, slower transit, and high fat intakes.